Evaluation of Perioperative Eltrombopag for the Management of Elective Surgery and Invasive Acts in Patients With Inherited Thrombocytopenia
Phase of Trial: Phase II
Latest Information Update: 21 Aug 2019
Price : $35 *
At a glance
- Drugs Eltrombopag (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- Acronyms ELPOT
- 19 Aug 2019 Planned End Date changed from 1 Sep 2021 to 1 Aug 2022.
- 19 Aug 2019 Planned primary completion date changed from 1 Mar 2021 to 1 Aug 2022.
- 21 Jan 2019 Status changed from not yet recruiting to recruiting.